Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum

2012 ◽  
Vol 734 ◽  
pp. 93-98 ◽  
Author(s):  
Jing-Yuan Hou ◽  
Tian-Cai Liu ◽  
Guan-Feng Lin ◽  
Zhi-Xiong Li ◽  
Li-Ping Zou ◽  
...  
RSC Advances ◽  
2014 ◽  
Vol 4 (98) ◽  
pp. 55229-55236 ◽  
Author(s):  
Guanfeng Lin ◽  
Hui Zhao ◽  
Tiancai Liu ◽  
Jingyuan Hou ◽  
Zhiqi Ren ◽  
...  

A magnetic nanoparticle-based dual-label TRFIA employing europium and samarium chelate labels for simultaneous determination of CYFRA 21-1 and CEA.


2013 ◽  
Vol 40 (7) ◽  
pp. 1114-1117
Author(s):  
Yuan LIU ◽  
Rong-Rong LIU ◽  
Xian-Jin Liu ◽  
Dun-Huang Fang ◽  
Cun-Man Song ◽  
...  

2015 ◽  
Vol 28 (3) ◽  
pp. 179-183 ◽  
Author(s):  
Juanjuan Chen ◽  
Tiancai Liu ◽  
Zhenhua Chen ◽  
Jingyuan Hou ◽  
Yingsong Wu ◽  
...  

2016 ◽  
Vol 22 (2) ◽  
pp. 130-135 ◽  
Author(s):  
Ling Wang ◽  
Mujuan Xu ◽  
Ruolan Huang ◽  
Xiao Chang ◽  
Cuicui Chen ◽  
...  

The aim of this study was to establish a dual-label time-resolved fluorescence immunoassay (TRFIA) for the simultaneous determination of cardiac troponin T (cTnT) and myoglobin (MYO) for the early diagnosis of acute myocardial infarction. The sandwich immunoassay was used to detect the concentration of cTnT and MYO in serum. cTnT and MYO in serum were captured by anti-cTnT and anti-MYO antibodies immobilized on microtiter wells and then banded together with another anti-cTnT and anti-MYO labeled with europium(III) Sm3+ and samarium(III) Eu3+ chelates, followed by fluorescence measurement using time-resolved fluorometry. The performance of this TRFIA was evaluated using the clinical serum and compared with the commercial assays. The linear correlation coefficients ( R2) of the cTnT and MYO standard curves were 0.9993 and 0.9995, respectively. The sensitivity for cTnT detection was 2.21 pg/mL (linear dynamic range was 3.24–963.71 pg/mL), and the average recovery was 100.57%. The sensitivity for MYO detection was 3.24 ng/mL (linear dynamic range was 4.95–976.85 ng/mL), and the average recovery was 99.79%. High correlation coefficients ( R2) were obtained between the commercial assays and dual-label TRFIA ( R2 = 0.999). The present dual-label TRFIA has high sensitivity, specificity, and accuracy in clinical sample analysis. It is a good alternative to the single-label diagnostic methods.


Sign in / Sign up

Export Citation Format

Share Document